Metr, powered by RJL, brings a new chapter for proven science.
After over 40 years of driving innovation in the field of BIA, RJL Systems is thrilled to announce an exciting new chapter: RJL has been acquired by Metr Health.
Since our founding in 1979, RJL Systems has been a pioneer in bioelectrical impedance analysis, building the most accurate and validated body composition technology on the market. With the acquisition by Metr, we are poised to enter a new phase of innovation and growth. Metr brings the RJL legacy new resources, new capabilities and a renewed commitment to the clinicians and patients who depend on it. As part of the acquisition, device support and current orders will continue uninterrupted.
The acquisition of RJL Systems is led by Metr Health leadership Michael Shields and Ward Detwiler, entrepreneurs with deep experience scaling technology and healthcare companies. Shields brings decades of leadership as a founder, CEO and investor across biosciences and advanced technology, while Detwiler brings a track record of commercializing medical and healthcare technology from concept to market. Together they connect RJL's validated science to the resources and expertise it needs to lead in today's standard of care.
We are excited to bring this great, proven technology into its next chapter, with fresh investment in analysis software, hardware updates and increased focus on client experience. The science that started it all now has the backing to lead what comes next.
Major advancements in BIA begin here. Over the next several months, you will be hearing several exciting new product releases as we continue to push BIA forward. We look forward to keeping you up to date as we begin this new journey.
Contact Us
We’re here to help. For questions about accounts, orders and support continuity, reach out to us using the form below.
